Lytix Biopharma AS Cash Flow Reinvestment Rate
Latest as of September 2021:
0.00x
Lytix Biopharma AS cash flow reinvestment rate. Lytix Biopharma AS (LYTIX) has a Cash Flow Reinvestment Rate of 0.00x as of September 2021, reinvesting Nkr35.00K (capex Nkr35.00K ) from operating cash flow of Nkr138.23 Million. Explore Lytix Biopharma AS cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
0.00x
(Capex + Investments) / Operating CF
Total Reinvested
Nkr35.00K
Capex + Investments
Operating Cash Flow
Nkr138.23 Million
NOK
Capital Expenditures
Nkr35.00K
NOK
Lytix Biopharma AS Cash Flow Reinvestment Rate by Year (None–None)
Lytix Biopharma AS cash flow reinvestment rate by year from None to None. Year-by-year capital reinvestment analysis for Lytix Biopharma AS. For the full cash flow conversion analysis, see LYTIX cash generation efficiency.
| Year | Reinvestment Rate | Total Reinvested (NOK) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow